PCRX (Pacira) Yalpi foyda bo'yicha sotuv rentabelligi

Pacira Pharmaceuticals (PCRX) korporativ emblemasi va logotipi

Joriy yalpi foyda Pacira BioSciences (PCRX) moliyaviy barqarorligini ko'rsatadi, bunda 71.30 ko'rsatkichi ushbu parametrni tavsiflaydi. Kompaniya uzoq muddatli, opioid bo'lmagan og'riqni qoldiruvchi noyob dori yetkazib berish usulini joriy etmoqda. Foydaning o'sishi klinikalarda Exparel ning kengayishi va sug'urta qamrovi hisobiga ta'minlanmoqda. FDA tasdig'i, generik raqobat xavfiga qaramay, bozorga kirish uchun yuqori to'siqlarni kafolatlaydi.

PCRX (Pacira BioSciences) Yalpi marja tarixi 04.07.2022dan 19.11.2026gacha

Pacira BioSciences (PCRX) moliyaviy va bozor koʻrsatkichlari kesimi

Fundamental baholash:PCRX - Pacira Pharmaceuticals
Pacira Corp tomonidan chiqariladigan mahsulotlar

Yalpi marja bevosita xarajatlarni chegirib tashlagandan keyingi foyda ulushini aniqlash orqali ishlab chiqarish samaradorligini o'lchaydi, bu esa investorlarga biznesning pul oqimini yaratish bo'yicha fundamental qobiliyatini baholash imkonini beradi. Yalpi rentabellikni tahlil qilish orqali treyderlar Exparel ning patent himoyasi va kompaniyaning narxlarni belgilash kuchiga ta'sir ko'rsatuvchi arzon generik dori vositalari paydo bo'lishi xavflari fonida Pacira BioSciences (PCRX) ning marja barqarorligini prognoz qiladilar.

Asosiy raqobatchilar

Yalpi foyda marjasi Haleon PLC (HLN)|Yalpi foyda bo'yicha rentabellik KVUE|Yalpi foyda marjasi Verona Pharma Inc. VRNA|Yalpi marja MENS|Ligand Pharmaceuticals - Sotuvning yalpi rentabelligi|Yalpi rentabellik Amneal AMRX|Sotuvning yalpi marjinal rentabelligi Perrigo Company PLC|Alvotech Biopharmaceuticals - Yalpi marja|Yalpi foyda bo'yicha sotuv rentabelligi Liquidia Technologies LQDA|Galapagos N.V. (GLPG) - Yalpi rentabellik|anipharmaceuticals.com - Yalpi foyda normasi|Yalpi foyda bo'yicha rentabellik MNKD|AMPH: Yalpi foyda normasi|Yalpi marja SPRY|TBPH - Yalpi foyda marjasi|Aquestive Pharma - Yalpi foyda bo'yicha rentabellik|Yalpi marja scpharmaceuticals.com SCPH|Tectonic - Yalpi marja|TNXP - Yalpi marja|SXTC: Yalpi marja|Eupraxia Pharma - Yalpi foyda normasi|BHST (bioharvest.com) - Yalpi marja|Sotuvning yalpi rentabelligi EXOZ (invizyne.com)|Yalpi marja ORMP|Yalpi foyda bo'yicha sotuv rentabelligi Entera Bio|Yalpi marja HYFT (MindWalk Holdings, Inc.)|ABVC BioPharma - Yalpi rentabellik|Cumberland Corp - Yalpi marja|QNTM - Yalpi marja|FibroGen, Inc. (FGEN) - Yalpi rentabellik|TELO: Yalpi foyda koeffitsiyenti|RANI (Rani Therapeutics Inc) - Yalpi marja|Yalpi foyda marjasi synergychc.com SNYR|Yalpi rentabellik Rallybio Corp. (RLYB)|LEXX - Yalpi foyda marjasi|Yalpi marja PULM (pulmatrix.com)|Yalpi foyda koeffitsiyenti PTHL (Pheton)|APM - Yalpi rentabellik|Yalpi foyda bo'yicha sotuv rentabelligi Lyra Therapeutics Inc LYRA|impactbiomedinc.com (IBO) - Yalpi rentabellik|TNF Pharma (TNFA) - Yalpi marja|YCBD (cbdmd.com) - Yalpi marja|Yalpi foyda bo'yicha rentabellik PainReform (PRFX)|Yalpi rentabellik Altamira Therapeutics (CYTO)|Yalpi foyda bo'yicha sotuv rentabelligi Lipella Pharma|Optinose - Yalpi foyda bo'yicha rentabellik|Yalpi foyda bo'yicha sotuv rentabelligi pieris.com (PIRS)|PROC - Yalpi rentabellik|Yalpi foyda bo'yicha marjinallik PTPI|QLI: Yalpi marja|Yalpi foyda marjasi ACELYRIN Inc. (SLRN)|TFFP (TFF Pharmaceuticals, Inc) - Yalpi marja